Who is harbour biomed? Harbour BioMed is a global clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics in oncology and immunological disease areas to address unmet patient’s needs.What is the uu emc and harbour biomed antibody discovery? The antibody discovered by UU, EMC and Harbour BioMed is extremely promising based on the mechanism by which it targets the virus and on its developability as a fully human protein," said Tom Hudson, M.D., Senior Vice President, Research and Development and Chief Scientific Officer, AbbVie.How harbour biomed discovered 47d11 fully humanized covid 19 antibody? By working with leading virology experts at Utrecht University and Erasmus University Medical Center in the Netherlands, Harbour BioMed discovered 47D11 fully humanized antibody against COVID-19 using its own antibody technology platform.What is the harbour antibody platform? We are building a robust pipeline with our integrated Harbour antibody platform, that enable us to develop highly differentiated antibodies against various disease targets with great potency and safety profiles.
Harbour BioMed is a global, clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics in the areas of oncology and immunological diseases to address unmet patient’s needs. We are building a robust pipeline with our integrated Harbour antibody platform, that enable us